202 related articles for article (PubMed ID: 29804697)
21. Quantification of diffuse myocardial fibrosis using CMR extracellular volume fraction and serum biomarkers of collagen turnover with histologic quantification as standard of reference.
Foussier C; Barral PA; Jerosh-Herold M; Gariboldi V; Rapacchi S; Gallon A; Bartoli A; Bentatou Z; Guye M; Bernard M; Jacquier A
Diagn Interv Imaging; 2021 Mar; 102(3):163-169. PubMed ID: 32830084
[TBL] [Abstract][Full Text] [Related]
22. Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent Outcome.
Schelbert EB; Fridman Y; Wong TC; Abu Daya H; Piehler KM; Kadakkal A; Miller CA; Ugander M; Maanja M; Kellman P; Shah DJ; Abebe KZ; Simon MA; Quarta G; Senni M; Butler J; Diez J; Redfield MM; Gheorghiade M
JAMA Cardiol; 2017 Sep; 2(9):995-1006. PubMed ID: 28768311
[TBL] [Abstract][Full Text] [Related]
23. Evolutional change in epicardial fat and its correlation with myocardial diffuse fibrosis in heart failure patients.
Wu CK; Tsai HY; Su MM; Wu YF; Hwang JJ; Lin JL; Lin LY; Chen JJ
J Clin Lipidol; 2017; 11(6):1421-1431. PubMed ID: 29050981
[TBL] [Abstract][Full Text] [Related]
24. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study.
Duca F; Kammerlander AA; Zotter-Tufaro C; Aschauer S; Schwaiger ML; Marzluf BA; Bonderman D; Mascherbauer J
Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27974408
[TBL] [Abstract][Full Text] [Related]
25. CMR-derived extracellular volume fraction (ECV) in asymptomatic heart transplant recipients: correlations with clinical features and myocardial edema.
Yuan Y; Cai J; Cui Y; Wang J; Alwalid O; Shen X; Cao Y; Zou Y; Liang B
Int J Cardiovasc Imaging; 2018 Dec; 34(12):1959-1967. PubMed ID: 30056496
[TBL] [Abstract][Full Text] [Related]
26. Myocardial extracellular volume fraction quantification in an animal model of the doxorubicin-induced myocardial fibrosis: a synthetic hematocrit method using 3T cardiac magnetic resonance.
Zhou Z; Wang R; Wang H; Liu Y; Lu D; Sun Z; Yang G; Xu L
Quant Imaging Med Surg; 2021 Feb; 11(2):510-520. PubMed ID: 33532252
[TBL] [Abstract][Full Text] [Related]
27. Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT.
Nacif MS; Kawel N; Lee JJ; Chen X; Yao J; Zavodni A; Sibley CT; Lima JA; Liu S; Bluemke DA
Radiology; 2012 Sep; 264(3):876-83. PubMed ID: 22771879
[TBL] [Abstract][Full Text] [Related]
28. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.
aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H
Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502
[TBL] [Abstract][Full Text] [Related]
29. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.
Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH
Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119
[TBL] [Abstract][Full Text] [Related]
30. Quantification of extracellular volume with cardiac computed tomography in patients with dilated cardiomyopathy.
Baggiano A; Conte E; Spiritigliozzi L; Mushtaq S; Annoni A; Carerj ML; Cilia F; Fazzari F; Formenti A; Frappampina A; Fusini L; Gaudenzi Asinelli M; Junod D; Mancini ME; Mantegazza V; Maragna R; Marchetti F; Penso M; Tassetti L; Volpe A; Baessato F; Guglielmo M; Rossi A; Rovera C; Andreini D; Rabbat MG; Guaricci AI; Pepi M; Pontone G
J Cardiovasc Comput Tomogr; 2023; 17(4):261-268. PubMed ID: 37147147
[TBL] [Abstract][Full Text] [Related]
31. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
[TBL] [Abstract][Full Text] [Related]
32. Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nakajo M; Maemura K; Arima S; Yoshiura T
Eur Radiol; 2020 Mar; 30(3):1679-1689. PubMed ID: 31728691
[TBL] [Abstract][Full Text] [Related]
33. 3D left ventricular extracellular volume fraction by low-radiation dose cardiac CT: assessment of interstitial myocardial fibrosis.
Nacif MS; Liu Y; Yao J; Liu S; Sibley CT; Summers RM; Bluemke DA
J Cardiovasc Comput Tomogr; 2013; 7(1):51-7. PubMed ID: 23333188
[TBL] [Abstract][Full Text] [Related]
34. Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.
Inui K; Asai K; Tachi M; Yoshinaga A; Izumi Y; Kubota Y; Murai K; Tsukada YT; Amano Y; Kumita S; Shimizu W
Heart Vessels; 2018 Oct; 33(10):1195-1203. PubMed ID: 29560528
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of extracellular volume quantification using dual-energy CT.
van Assen M; De Cecco CN; Sahbaee P; Eid MH; Griffith LP; Bauer MJ; Savage RH; Varga-Szemes A; Oudkerk M; Vliegenthart R; Schoepf UJ
J Cardiovasc Comput Tomogr; 2019; 13(1):81-84. PubMed ID: 30377090
[TBL] [Abstract][Full Text] [Related]
36. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
[TBL] [Abstract][Full Text] [Related]
37. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance.
Barison A; Gargani L; De Marchi D; Aquaro GD; Guiducci S; Picano E; Cerinic MM; Pingitore A
Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):74-80. PubMed ID: 25190071
[TBL] [Abstract][Full Text] [Related]
38. Probing the intravascular and interstitial compartments of remodeled myocardium in heart failure patients with preserved and reduced ejection fraction: a CMR study.
Masci PG; Pavon AG; Berchier G; Schwitter J
BMC Med Imaging; 2019 Jan; 19(1):1. PubMed ID: 30611240
[TBL] [Abstract][Full Text] [Related]
39. Noninvasive hematocrit assessment for cardiovascular magnetic resonance extracellular volume quantification using a point-of-care device and synthetic derivation.
Robison S; Karur GR; Wald RM; Thavendiranathan P; Crean AM; Hanneman K
J Cardiovasc Magn Reson; 2018 Mar; 20(1):19. PubMed ID: 29544519
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy.
Barison A; Del Torto A; Chiappino S; Aquaro GD; Todiere G; Vergaro G; Passino C; Lombardi M; Emdin M; Masci PG
J Cardiovasc Med (Hagerstown); 2015 Oct; 16(10):681-7. PubMed ID: 26090916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
